This may be a result of the questions posed last week by Senator Grassley. It is getting even more complicated as insurance companies work on new algorithms to create new insurance plans and add them to the large pool of plans offered and it does not appear to be getting any easier to be able...
Posted to
The Medical Quack .... by Barbara Duck
on 11-09-2008
Filed under: Medically Related, Insurance, My Commentaries, healthcare, medicare, AARP, Congress, Medicaid, software, Patient Advocacy, Health Insuance, United HealthCare
This story about Walgreens illustrates a little bit of both. After the economy and Wall Street news of the last couple of weeks, we should know now about how programmers set algorithms to select, process and deliver data. Need a refresher, you can check here relative to Wall Street out coding...
Posted to
The Medical Quack .... by Barbara Duck
on 10-01-2008
Filed under: Medically Related, Technology, Insurance, My Commentaries, drugs, healthcare, Prescriptions, Medicaid, Medications, Medicare contractor, Whistle Blower, Data, Data Base, Algorithms
Hospice is not an issue anyone really wants to take a full look at, that is unless you or a family member are impacted. Budget cuts are already making things difficult in this area, so sad we have to resort to continued legal actions to allow the funds needed to care for seniors who need the care...
Dr. Doug Farrago with his input on what's happening in Massachusetts with their healthcare system. Long and short of all of this, is who's going to pay the bill? I feature Dr. Farrago under my "Need a Laugh" section as he produces new videos, I like his humor and unique...
Posted to
The Medical Quack .... by Barbara Duck
on 08-11-2008
Filed under: Medically Related, Insurance, My Commentaries, healthcare, medicare, Medicaid, Placebo Journal, Dr. Farrago, Massachusetts
The practice wrote and went directly to the governor’s office. Around 10- 15k stand to lose their primary care providers if this happens. The doctors stated it was an “economical” decision, and with the recent “economical” decisions in the drug industry, those may not always be the best. ...